Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C Ray

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Therapeutic Patents|May 16, 2009
Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent reviewNicholas C Ray, Lilian Alcaraz
Organic Letters|February 15, 2002
A solid-phase route to N-cyanoamidesTrevor Morgan, Nicholas C Ray, David M Parry
Bioorganic & Medicinal Chemistry Letters|October 23, 2013
The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPDAntonio Mete, Keith Bowers, Richard J Bull, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2012
Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the ratHazel J Hunt, Nicholas C Ray, George Hynd, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulatorsNicholas C Ray, Robin D Clark, David E Clark, et al.
Bioorganic & Medicinal Chemistry Letters|September 8, 2007
2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonistsRobin D Clark, Nicholas C Ray, Paul Blaney, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activityRobin D Clark, Nicholas C Ray, Karen Williams, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationshipsGeorge M Buckley, Natasha Davies, Hazel J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitorsHelen L Birch, George M Buckley, Natasha Davies, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2019
Discovery of a C-8 hydroxychromene as a potent degrader of estrogen receptor alpha with improved rat oral exposure over GDC-0927Sharada S Labadie, Jun Li, Robert A Blake, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|May 16, 2009
Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent reviewNicholas C Ray, Lilian Alcaraz
Organic Letters|February 15, 2002
A solid-phase route to N-cyanoamidesTrevor Morgan, Nicholas C Ray, David M Parry
Bioorganic & Medicinal Chemistry Letters|October 23, 2013
The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPDAntonio Mete, Keith Bowers, Richard J Bull, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2012
Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the ratHazel J Hunt, Nicholas C Ray, George Hynd, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulatorsNicholas C Ray, Robin D Clark, David E Clark, et al.
Bioorganic & Medicinal Chemistry Letters|September 8, 2007
2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonistsRobin D Clark, Nicholas C Ray, Paul Blaney, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activityRobin D Clark, Nicholas C Ray, Karen Williams, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationshipsGeorge M Buckley, Natasha Davies, Hazel J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitorsHelen L Birch, George M Buckley, Natasha Davies, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2019
Discovery of a C-8 hydroxychromene as a potent degrader of estrogen receptor alpha with improved rat oral exposure over GDC-0927Sharada S Labadie, Jun Li, Robert A Blake, et al.
Pageof 2